Overview
TPHA detects antibodies to T. pallidum antigens using sensitized erythrocytes; TPPA is a related particle agglutination method.
Clinical Importance
Confirm reactive nontreponemal tests
Serve as treponemal assay in traditional or reverse syphilis algorithms
Specimen Requirements
- Specimen: serum (preferred for most serology/autoimmune immunoassays) or plasma when the method is validated
- Tube: gold/SST (serum separator) or red-top serum; follow method-specific plasma acceptability
- Handling: allow SST to clot fully; centrifuge and separate promptly; avoid repeated freeze–thaw
- Storage: refrigerate short-term; freeze aliquots for delayed testing per manufacturer stability
- Stability: analyte- and kit-specific; do not exceed validated time/temperature limits
Analytical Method
Patient serum is mixed with T. pallidum–sensitized particles/cells; agglutination indicates treponemal antibodies. Does not distinguish active from treated remote infection.
Instruments Used
Automated analyzers
- Automated RPR analyzers (selected laboratories)
- Automated treponemal immunoassays (CLIA/ELISA) on major immunoassay platforms
- Roche Cobas immunoassay systems
- Abbott Alinity / Architect immunoassay systems
- Siemens Healthineers Atellica / ADVIA Centaur immunoassay systems
- Beckman Coulter Access / DxI immunoassay systems
Manual methods
- Manual RPR/VDRL flocculation cards
- Manual TPHA/TPPA and FTA-ABS fluorescence reading
Reference Values
Assay cutoffs, units, and reference intervals are method- and manufacturer-specific. Always interpret against the performing laboratory report (CLSI EP28-A3c for quantitative intervals where applicable). Serologic patterns require clinical correlation and current guideline algorithms (WHO/CDC/society guidance as adopted locally).
Nonreactive expected without syphilis exposure. Reactive treponemal tests typically persist after treatment.
Interpretation
Common Causes of Increased Results
- TPHA reactive; treponemal exposure (past or present); interpret with RPR/VDRL titer and history
Common Causes of Decreased Results
- TPHA nonreactive; argues against syphilis if performed adequately (early primary may still be negative)
Clinical Significance
- Syphilis confirmatory testing
Factors Affecting Results
Pre-analytical
- Hemolysis, lipemia, or icterus (assay-dependent interference)
- Wrong tube type or incomplete clotting of SST
- Repeated freeze–thaw of serum aliquots
- Testing too early or too late relative to infection/vaccination timing for serology
Analytical
- Calibration/QC failure; reagent lot shifts
- Hook effect / antigen excess on selected immunoassays
- Heterophile antibodies, rheumatoid factor, or biotin interference (assay-dependent)
Post-analytical
- Applying another laboratory’s cutoff to a different method
- Interpreting a single serology result without clinical timing and confirmatory algorithms
Advantages and Limitations
Advantages
- Higher specificity than RPR/VDRL
Limitations
- Remains positive after cure
- Not ideal alone for monitoring treatment
Clinical Pearls
Treponemal tests remember forever; use nontreponemal titers to watch treatment, not TPHA.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods (verify current edition). Chapters on clinical immunology and serology.
- Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (verify current edition). Immunoassay and protein chapters.
CLSI and Professional Guidelines
- Centers for Disease Control and Prevention. Laboratory testing recommendations for infectious disease serology and related algorithms (verify current CDC guidance for the pathogen).
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. CLSI document EP28-A3c (verify current edition).
- Clinical and Laboratory Standards Institute. Immunoassay and related method evaluation documents (e.g., EP05, EP06, EP07, EP17; verify current editions relevant to the assay).
- College of American Pathologists. Accreditation and proficiency testing expectations for immunology/serology (verify current CAP checklist requirements).
- International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Recommendations relevant to protein and immunoassay measurands (verify current IFCC documents).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance for serologic and immunologic testing (verify current WHO publication for the analyte/assay).
Frequently Asked Questions
Common questions about using this TPHA laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the TPHA laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of TPHA. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find TPHA specimen requirements?
See the Specimen Requirements section on this page for specimen information related to TPHA. Confirm collection details against your laboratory protocol.
Where are TPHA reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret TPHA results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for TPHA?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from TPHA?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading TPHA?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Immunology & Serology topic.
What are the clinical pearls for TPHA?
See the Clinical Pearls section for concise laboratory practice notes associated with TPHA. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.